Re: Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency
(Source: BMJ Comments)
Source: BMJ Comments - April 9, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts
(Source: BMJ Comments)
Source: BMJ Comments - April 7, 2021 Category: General Medicine Source Type: forums
Role of Testing for ADAMTS13 enzyme deficiency in patients with clots after Covid-19 infection and/or AstraZeneca vaccine.
(Source: BMJ Comments)
Source: BMJ Comments - April 7, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts
(Source: BMJ Comments)
Source: BMJ Comments - April 7, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: AstraZeneca vaccine and SARS-CoV-2 positivity?
(Source: BMJ Comments)
Source: BMJ Comments - April 1, 2021 Category: General Medicine Source Type: forums
Re: Yellow Card reports compared for Oxford/AstraZeneca and PfizerBioNTech products
(Source: BMJ Comments)
Source: BMJ Comments - March 31, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: AstraZeneca vaccine prevents 79% of symptomatic disease and 100% of severe disease, US study finds
(Source: BMJ Comments)
Source: BMJ Comments - March 27, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency
(Source: BMJ Comments)
Source: BMJ Comments - March 22, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety
(Source: BMJ Comments)
Source: BMJ Comments - March 20, 2021 Category: General Medicine Source Type: forums
Re: Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
(Source: BMJ Comments)
Source: BMJ Comments - March 17, 2021 Category: General Medicine Source Type: forums
